May 11, 2015
Endo Pharmaceuticals Inc. asked a California federal court Friday to ax Walgreens Boots Alliance Inc. and Kroger Co.'s lawsuit, saying because they didn't buy the pain patch directly from the drugmaker, they couldn't challenge its Lidoderm patent settlements.
May 05, 2015
A California federal judge on Tuesday pared some state antitrust and consumer protection claims from multidistrict litigation lodged against Endo Pharmaceuticals Inc. and two other pharmaceutical companies over an alleged pay-for-delay deal for the pain medication Lidoderm while letting others proceed.
April 21, 2015
Rite Aid Corp. on Tuesday moved to be the latest pharmacy to try entering the Lidoderm pay-for-delay multidistrict litigation in California federal court, alleging that Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co. Ltd. paid at least $266 million to delay generic versions of the pain patch.
March 05, 2015
Walgreens Co., The Kroger Co. and other grocery stores sought to enter the Lidoderm pay-for-delay multidistrict litigation in California federal court, accusing Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co. Ltd. of paying at least $266 million to delay generic versions of the pain patch.
February 03, 2015
Endo Pharmaceuticals Inc. and two other drugmakers have pushed a California federal court overseeing the Lidoderm multidistrict litigation to pare down state antitrust claims from updated complaints end payors and the Government Employees Health Association filed over an alleged pay-for-delay deal for the pain medication.
November 18, 2014
A California federal judge on Tuesday preserved the bulk of consolidated antitrust multidistrict litigation accusing Endo Pharmaceuticals Inc., Teikoku Seiyaku Co. Ltd., and Watson Pharmaceuticals Inc. of illegally deferring competition from Watson’s planned Lidoderm generic by giving Watson pharmaceuticals and promises of product delays worth $170 million. (Correction: An earlier story didn’t clearly explain that the main federal antitrust claims against the defendants are moving forward. The error has been corrected.)
November 05, 2014
A California federal judge said Wednesday he would likely throw out allegations in multidistrict litigation that Endo Pharmaceuticals Inc. and Teikoku Seiyaku Co., Ltd. shared a monopoly in the market for the Lidoderm pain-relief patch, saying only one entity can be accused of holding a monopoly.
September 09, 2014
Consumers and others who bought Lidoderm pain patches hit back Monday at a bid by Endo Pharmaceuticals Inc. and other drugmakers to dismiss multidistrict litigation accusing them of using a patent settlement to delay a generic version of the treatment.
July 29, 2014
Endo Pharmaceuticals Inc., Teikoku Seiyaku Co. Ltd. and Watson Pharmaceuticals Inc. urged a California federal judge on Monday to dismiss several suits in multidistrict litigation accusing them of illegally agreeing to delay a generic version of the Lidoderm pain relief patch, arguing the deal was perfectly lawful.